CTH | According to Dr Pierre Kory, MD, MPA, and verified by the Front Line COVID-19 Critical Care Alliance (FLCCC), 100 to 200 congressional reps and/or staff and families who contracted COVID-19 were treated with the Front Line Ivermectin protocol.
Fun fact: Between 100-200 United States Congress Members (plus many of their staffers & family members) with COVID.. were treated by a colleague over the past 15 months with ivermectin & the I-MASK+ protocol at https://t.co/OvU8SLfLJq. None have gone to hospital. Just sayin'
— Pierre Kory, MD MPA (@PierreKory) October 8, 2021
This successful treatment is happening at the same time many congressional representatives are playing politics in favor of the vaccine; downplaying the effective anti-viral treatment and therapeutic approach with Ivermectin; and taking action to block regular American citizens from seeking similar treatment with Ivermectin.
Congress can seek treatment with a medication they simultaneously deny to others? This is well beyond a “scandal”, and needs to be investigated quickly.
Friends, we would not have tweeted something of this magnitude and importance without knowing for certain that it was true, and that the source was unassailable. https://t.co/V7XUZkqLOt
— Frontline Covid-19 Critical Care (@Covid19Critical) October 8, 2021
Additionally, as Merck has announced a new and similar anti-viral drug called Molnupiravir, two trial studies in India have requested to exit the trials. Apparently the issue surrounds the new drug providing no benefit once a patient is moderately ill and hospitalized (READ MORE, Reuters Link).
0 comments:
Post a Comment